TipRanks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market
9IB
Infant Bacterial Therapeutics AB
RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Ratios

4 Followers

Infant Bacterial Therapeutics AB Ratios

DE:9IB's free cash flow for Q2 2026 was kr0.00. For the 2026 fiscal year, DE:9IB's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.67 2.72 3.33 7.40 18.93
Quick Ratio
 1.67 2.72 3.33 7.40 18.93
Cash Ratio
 1.62 2.55 3.22 7.13 18.75
Solvency Ratio
 -1.21 -1.14 0.12 0.25 -3.61
Operating Cash Flow Ratio
 -0.95 -1.28 -1.63 -2.19 -4.79
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 45.29Mkr 97.19Mkr 161.31Mkr 295.38Mkr 321.12M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.27 1.54 1.41 1.15 1.05
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 -219.60
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -224.60
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 0.03
Net Debt to EBITDA
 1.32 2.11 1.63 -28.49 5.22
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%100.00%
EBIT Margin
0.00%0.00%-3422625.00%-159828.57%-545425.00%
EBITDA Margin
0.00%0.00%-3422625.00%14998.70%-536183.33%
Operating Profit Margin
0.00%0.00%-3497550.00%-174827.27%-548400.00%
Pretax Profit Margin
0.00%0.00%-3422625.00%-159828.57%-545425.00%
Net Profit Margin
0.00%0.00%-3422625.00%-159828.57%-545425.00%
Continuous Operations Profit Margin
0.00%0.00%-3422625.00%-159828.57%-545425.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
96.25%105.19%97.86%91.42%99.46%
Return on Assets (ROA)
-68.14%-40.29%-57.15%-35.03%-18.72%
Return on Equity (ROE)
-89.70%-61.87%-80.41%-40.33%-19.73%
Return on Capital Employed (ROCE)
-160.52%-58.82%-82.17%-44.11%-19.84%
Return on Invested Capital (ROIC)
-160.52%-58.82%-82.17%-44.11%-19.84%
Return on Tangible Assets
-72.78%-42.40%-59.35%-36.02%-19.30%
Earnings Yield
-9.36%-9.58%-18.96%-11.06%-11.66%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 <0.01 0.01 <0.01
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 0.00 0.00 <0.01 <0.01 <0.01
Cash Conversion Cycle
 0.00 0.00 434.90K 31.93K 54.08K
Days of Sales Outstanding
 0.00 0.00 434.90K 31.93K 54.08K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 434.90K 31.93K 54.08K
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.76 -5.37 -8.40 -8.19 -7.64
Free Cash Flow Per Share
 -4.76 -5.37 -8.40 -8.19 -7.64
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 -28.28K -1.31K -7.15K
Free Cash Flow Yield
-7.57%-10.63%-15.67%-9.10%-15.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.67 -10.43 -5.28 -9.04 -8.58
Price-to-Sales (P/S) Ratio
 0.00 0.00 180.52K 14.45K 46.78K
Price-to-Book (P/B) Ratio
 16.51 6.46 4.24 3.65 1.69
Price-to-Free Cash Flow (P/FCF) Ratio
 -13.21 -9.40 -6.38 -10.99 -6.54
Price-to-Operating Cash Flow Ratio
 -13.67 -9.40 -6.38 -10.99 -6.54
Price-to-Earnings Growth (PEG) Ratio
 -0.96 0.20 -2.50 -0.13 -0.19
Price-to-Fair Value
 16.51 6.46 4.24 3.65 1.69
Enterprise Value Multiple
 -8.99 -7.87 -3.64 67.86 -3.50
Enterprise Value
 737.58M 536.30M 498.68M 783.75M 225.47M
EV to EBITDA
 -8.99 -7.87 -3.64 67.86 -3.50
EV to Sales
 0.00 0.00 124.67K 10.18K 18.79K
EV to Free Cash Flow
 -11.51 -7.41 -4.41 -7.74 -2.63
EV to Operating Cash Flow
 -11.51 -7.41 -4.41 -7.74 -2.63
Tangible Book Value Per Share
 3.37 7.22 11.98 23.89 28.61
Shareholders’ Equity Per Share
 3.94 7.82 12.64 24.68 29.55
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 <0.01 <0.01 <0.01
Net Income Per Share
 -6.08 -4.84 -10.16 -9.95 -5.83
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.99 0.94 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 30.15K 1.57K 5.49K
SG&A to Revenue
 0.00 0.00 4.82K 175.47 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.78 1.11 0.78 0.82 1.30
Currency in SEK